PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.\', \'Department of Biomedical Sciences, Gulf Medical University, Ajman, United Arab Emirates.\', \'Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehra Dun, Uttarakhand, India.\', \'Natural Product Discovery Laboratory, Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, SHUATS, Naini, Prayagraj, India.\', \'King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2174/0929867327666200903115138
?:doi
?:hasPublicationType
?:journal
  • Current medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 32881656
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.015
?:rankingScore_hIndex
  • 153
is ?:relation_isRelatedTo_publication of
?:title
  • Targeting COVID-19 in Parkinson\'s Patients: Drugs Repurposed.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32881656>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32881656>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all